FTO (freedom to operate) in the pharmaceutical industry
FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to pe...
| Otros Autores: | |
|---|---|
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Baden-Baden, Germany :
Nomos Verlagsgesellschaft mbH & Co. KG
2018
2018. |
| Edición: | First edition |
| Colección: | MIPLC studies ;
Volume 34. |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009432215906719 |
| Sumario: | FTO licensing in the pharmaceutical industry deserves special consideration because of the large economic scale of the market, expensive cost of R&D, extremely low success rate, and easy duplication of the drug. Taking these unique aspects into consideration, the author first explaines how to perform a good FTO search and conclude an appropriate FTO licensing agreement, and then points out two issues; (i) the issue of FTO licensing and EU competition, especially the unreasonable application of the Guideline, and (ii) the issue of FTO licensing and differentiating between a bio venture company and a pharmaceutical company. Solutions for these issues are proposed. |
|---|---|
| Descripción Física: | 1 online resource (64 pages) |
| Bibliografía: | Includes bibliographical references. |
| ISBN: | 9783845294018 |
